Celeris TherapeuticsBetter drugs faster
Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets. Celeris One exploits the potential of degrader technologies with accurate predictions of biomolecular interactions and the expansion of chemical space. Deep learning serves as an enabler.
Christopher Trummer, Jakob Hohenberger
Life Sciences, AI, in-silico drug discovery